Philip S Low Selected Research

Folic Acid (Vitamin M)

1/2022	Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis.
1/2022	Targeted delivery of acrolein scavenger hydralazine in spinal cord injury using folate-linker-drug conjugation.
1/2022	Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.
1/2021	Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis.
1/2021	Intraoperative Molecular Imaging Utilizing a Folate Receptor-Targeted Near-Infrared Probe Can Identify Macroscopic Gastric Adenocarcinomas.
1/2021	Folate-targeted verrucarin A reduces the number of activated macrophages in a mouse model of acute peritonitis.
1/2021	Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
12/2020	Radiosynthesis and preclinical evaluation of [68Ga]Ga-NOTA-folate for PET imaging of folate receptor β-positive macrophages.
11/2020	Folate Receptor β-Targeted PET Imaging of Macrophages in Autoimmune Myocarditis.
10/2020	Fluorescence Labeling of Circulating Tumor Cells with a Folate Receptor-Targeted Molecular Probe for Diffuse In Vivo Flow Cytometry.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip S Low Research Topics

Disease

121	Neoplasms (Cancer) 10/2022 - 05/2002
21	Inflammation (Inflammations) 10/2021 - 07/2002
19	Rheumatoid Arthritis 01/2022 - 04/2004
14	Arthritis (Polyarthritis) 01/2022 - 07/2002
10	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2011
9	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 09/2004
9	Atherosclerosis 01/2018 - 05/2005
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2007
8	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 10/2008
7	Lung Neoplasms (Lung Cancer) 01/2018 - 05/2002
6	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 06/2003
6	Malaria 10/2021 - 03/2004
6	Adenocarcinoma 01/2021 - 02/2013
6	Carcinoma (Carcinomatosis) 12/2018 - 09/2004
5	Infections 01/2021 - 03/2004
5	Ovarian Epithelial Carcinoma 10/2019 - 03/2008
5	Adenocarcinoma of Lung 01/2017 - 01/2014
4	Circulating Neoplastic Cells 01/2022 - 07/2007
4	Parasitemia 10/2021 - 01/2016
4	Bone Fractures (Bone Fracture) 10/2021 - 10/2015
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2020 - 10/2015
4	Ulcerative Colitis 01/2019 - 07/2012
4	Atherosclerotic Plaque (Atheroma) 01/2018 - 05/2005
4	Rupture 11/2016 - 11/2002
4	Experimental Arthritis 08/2016 - 01/2006
4	Breast Neoplasms (Breast Cancer) 05/2016 - 09/2007
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 02/2013
3	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2021 - 01/2016
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 04/2015
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2018 - 12/2013
3	Hypoxia (Hypoxemia) 10/2018 - 07/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 05/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 04/2008
2	Osteoarthritis 01/2022 - 01/2008
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2019
2	Cytokine Release Syndrome 10/2021 - 01/2019
2	Peritonitis 01/2021 - 01/2019
2	Human Influenza (Influenza) 01/2021 - 11/2020
2	Fibrosis (Cirrhosis) 10/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

114	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 05/2002
36	LigandsIBA 01/2022 - 10/2003
23	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
18	PafolacianineIBA 10/2022 - 01/2016
17	Coloring Agents (Dyes)IBA 01/2022 - 04/2005
17	Folate Receptor 1IBA 08/2021 - 09/2006
16	Fluorescent Dyes (Fluorescent Probes)IBA 01/2022 - 10/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
13	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 05/2002
13	HaptensIBA 01/2017 - 05/2002
12	AntigensIBA 01/2022 - 04/2004
10	AntibodiesIBA 01/2022 - 08/2003
9	Contrast MediaIBA 01/2022 - 01/2008
8	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 06/2011
8	Chimeric Antigen ReceptorsIBA 01/2022 - 05/2015
7	Folate Receptor 2IBA 01/2022 - 01/2015
7	Fluorescein-5-isothiocyanate (FITC)IBA 01/2019 - 01/2006
7	Liposomes (Liposome)IBA 01/2018 - 09/2004
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2006
6	AcidsIBA 01/2021 - 05/2007
6	VitaminsIBA 12/2008 - 05/2002
5	Peptides (Polypeptides)IBA 10/2021 - 01/2015
5	tubulysin BIBA 01/2020 - 07/2015
5	CytokinesIBA 01/2020 - 05/2002
5	Monoclonal AntibodiesIBA 01/2019 - 07/2009
5	Carbonic Anhydrase IXIBA 10/2018 - 01/2016
5	EnzymesIBA 01/2018 - 09/2006
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 09/2005
4	poly(ethylene glycol)-folateIBA 01/2020 - 03/2013
4	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2020 - 01/2016
4	Cell Surface ReceptorsIBA 12/2019 - 05/2002
4	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2006
4	Cholecystokinin B ReceptorIBA 03/2016 - 02/2014
3	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 01/2016
3	Complement System Proteins (Complement)IBA 12/2019 - 09/2005
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 07/2015
3	isothiocyanic acidIBA 01/2019 - 06/2008
3	Protein Isoforms (Isoforms)IBA 01/2018 - 07/2012
3	SpectrinIBA 11/2016 - 08/2006
3	RadiopharmaceuticalsIBA 01/2016 - 07/2002
3	Indicators and Reagents (Reagents)IBA 06/2015 - 05/2009
3	Interleukin-2 (IL2)IBA 05/2014 - 05/2002
2	BuffersIBA 01/2022 - 11/2005
2	Biotin (Vitamin H)FDA Link 01/2022 - 11/2016
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
2	Phosphotransferases (Kinase)IBA 10/2021 - 11/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2021 - 01/2016
2	OligopeptidesIBA 10/2021 - 11/2018
2	AminopterinIBA 01/2021 - 04/2011
2	AluminumIBA 11/2020 - 01/2018
2	CollagenIBA 10/2020 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 01/2020 - 09/2007
2	Syk KinaseIBA 01/2020 - 01/2017
2	Biological ProductsIBA 03/2019 - 04/2008
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2019 - 01/2018

Therapy/Procedure

63	Therapeutics 01/2022 - 09/2002
17	Immunotherapy 01/2021 - 05/2002
8	Drug Therapy (Chemotherapy) 01/2019 - 08/2003
5	Cytoreduction Surgical Procedures 10/2019 - 09/2011
3	Lasers (Laser) 10/2022 - 10/2003
3	Intravenous Injections 01/2017 - 06/2013